GILEAD SCIENCES, INC. (GILD)

Latest Insider Confidence Score

2026Q1

46.1
Bearish

Company insider confidence (by quarter)

2016Q4 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Gilead Sciences, Inc. 10% Owner 31,424,760 Feb 20, 2025
Martin John C Director 2,887,225 Feb 8, 2019
Bischofberger Norbert W EVP, R&D and CSO 2,317,800 Feb 23, 2018
O'Day Daniel Patrick CEO 571,203 Dec 1, 2025
Milligan John F CEO 280,000 Nov 29, 2018

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 27, 2026 Mar 2, 2026 Dickinson Andrew D CFO Neutral 85.0 +11,090 6.61% ✗ -
Feb 27, 2026 Mar 2, 2026 Mercier Johanna Chief Comm & Corp Aff Officer Neutral 85.0 +11,090 9.22% ✗ -
Feb 27, 2026 Mar 2, 2026 Berger Dietmar Chief Medical Officer Neutral 90.0 +8,530 90.92% ✗ -
Feb 27, 2026 Mar 2, 2026 Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp Neutral 90.0 +470 11.92% ✗ -
Feb 27, 2026 Mar 2, 2026 O'Day Daniel Patrick CEO Sell 92.5 +28,396 4.63% ✓ $1.4M
Feb 17, 2026 Feb 18, 2026 Mercier Johanna Chief Comm & Corp Aff Officer Sell 18.8 -28,000 -18.88% ✓ $4.3M
Feb 17, 2026 Feb 18, 2026 Dickinson Andrew D CFO Sell 45.0 -3,000 -1.76% ✓ $463.3K
Feb 12, 2026 Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp Neutral 52.5 - 0.00% ✗ -
Feb 5, 2026 Feb 6, 2026 O'Day Daniel Patrick CEO Sell 17.5 -115,640 -15.85% ✓ $17.3M
Feb 3, 2026 Feb 5, 2026 Mercier Johanna Chief Comm & Corp Aff Officer Sell 100.0 +20,067 19.44% ✗ $3.6M
Feb 3, 2026 Feb 5, 2026 Dickinson Andrew D CFO Sell 100.0 +20,065 13.33% ✗ $3.6M
Feb 3, 2026 Feb 5, 2026 O'Day Daniel Patrick CEO Sell 100.0 +57,214 10.28% ✗ $10.7M
Jan 28, 2026 Jan 29, 2026 O'Day Daniel Patrick CEO Sell 43.8 -10,000 -1.76% ✓ $1.4M
Jan 23, 2026 Jan 26, 2026 O'Day Daniel Patrick CEO Sell 17.5 -115,640 -16.95% ✓ $15.6M
Jan 20, 2026 Jan 21, 2026 Bluestone Jeffrey Director Sell 10.0 -5,000 -35.92% ✓ $617.5K
Jan 15, 2026 Jan 16, 2026 Dickinson Andrew D CFO Sell 45.0 -3,000 -1.95% ✓ $372.9K
Jan 15, 2026 Jan 16, 2026 Mercier Johanna Chief Commercial Officer Sell 41.3 -3,000 -2.82% ✓ $372.9K
Jan 2, 2026 Jan 5, 2026 Berger Dietmar Chief Medical Officer Sell 20.0 -6,944 -42.53% ✗ $844.4K
Dec 29, 2025 Dec 30, 2025 O'Day Daniel Patrick CEO Sell 43.8 -10,000 -1.73% ✓ $1.2M
Dec 15, 2025 Dec 16, 2025 Dickinson Andrew D CFO Sell 42.5 -3,000 -1.92% ✓ $366K
Dec 15, 2025 Dec 16, 2025 Mercier Johanna Chief Commercial Officer Sell 38.8 -3,000 -2.75% ✓ $366K
Dec 10, 2025 Dec 11, 2025 Dickinson Andrew D CFO Sell 22.5 -1,745 -1.10% ✗ $211.7K
Dec 10, 2025 Dec 11, 2025 O'Day Daniel Patrick CEO Sell 30.0 -4,931 -0.85% ✗ $598.3K
Dec 10, 2025 Dec 11, 2025 Mercier Johanna Chief Commercial Officer Sell 22.5 -1,814 -1.63% ✗ $220.1K
Nov 28, 2025 Dec 1, 2025 Bluestone Jeffrey Director Sell 20.0 -5,000 -35.92% ✗ $625.4K
Nov 26, 2025 Dec 1, 2025 Kramer Kelly A. Director Sell 7.5 -5,611 -67.69% ✓ $713.2K
Nov 28, 2025 Dec 1, 2025 O'Day Daniel Patrick CEO Sell 40.0 -10,000 -1.72% ✓ $1.3M
Nov 17, 2025 Nov 18, 2025 Dickinson Andrew D CFO Sell 42.5 -2,500 -1.59% ✓ $313.1K
Nov 17, 2025 Nov 18, 2025 Mercier Johanna Chief Commercial Officer Sell 10.0 -28,000 -20.71% ✓ $3.5M
Nov 12, 2025 Nov 13, 2025 Telman Deborah H EVP, Corporate Affairs & GC Sell 3.8 -53,646 -29.05% ✓ $6.6M
Oct 28, 2025 Oct 29, 2025 O'Day Daniel Patrick CEO Sell 40.0 -10,000 -1.69% ✓ $1.2M
Oct 25, 2025 Oct 27, 2025 Telman Deborah H EVP, Corporate Affairs & GC Sell 36.3 -241 -0.55% ✗ $29.1K
Oct 15, 2025 Oct 16, 2025 Dickinson Andrew D CFO Sell 42.5 -2,500 -1.57% ✓ $295.2K
Oct 15, 2025 Oct 16, 2025 Mercier Johanna Chief Commercial Officer Sell 38.8 -3,000 -2.65% ✓ $354.2K
Sep 29, 2025 Sep 30, 2025 O'Day Daniel Patrick CEO Sell 40.0 -10,000 -1.66% ✓ $1.1M
Sep 22, 2025 Sep 23, 2025 Burkhart Erin SVP, Controllership Neutral 52.5 - 0.00% ✗ -
Sep 23, 2025 Burkhart Erin SVP, Controllership Neutral 52.5 - 0.00% ✗ -
Sep 15, 2025 Sep 16, 2025 Mercier Johanna Chief Commercial Officer Sell 38.8 -3,000 -2.58% ✓ $340.7K
Sep 15, 2025 Sep 16, 2025 Dickinson Andrew D CFO Sell 42.5 -2,500 -1.54% ✓ $283.9K
Sep 10, 2025 Sep 11, 2025 O'Day Daniel Patrick CEO Sell 30.0 -4,949 -0.82% ✗ $570.4K
Sep 10, 2025 Sep 11, 2025 Wilfong Diane E. Interim Corp Controller & CAO Sell 36.3 -338 -0.73% ✗ $39K
Sep 10, 2025 Sep 11, 2025 Telman Deborah H EVP, Corporate Affairs & GC Sell 22.5 -634 -1.44% ✗ $73.1K
Sep 10, 2025 Sep 11, 2025 Mercier Johanna Chief Commercial Officer Sell 22.5 -1,819 -1.54% ✗ $209.6K
Sep 10, 2025 Sep 11, 2025 Dickinson Andrew D CFO Sell 22.5 -1,751 -1.07% ✗ $201.8K
Aug 28, 2025 Aug 29, 2025 O'Day Daniel Patrick CEO Sell 40.0 -10,000 -1.65% ✓ $1.1M
Aug 15, 2025 Aug 18, 2025 Mercier Johanna Chief Commercial Officer Sell 32.5 -28,000 -3.86% ✓ $3.3M
Aug 15, 2025 Aug 18, 2025 Dickinson Andrew D CFO Sell 42.5 -2,500 -1.54% ✓ $296.3K
Jul 28, 2025 Jul 29, 2025 O'Day Daniel Patrick CEO Sell 40.0 -10,000 -1.62% ✓ $1.1M
Jul 25, 2025 Jul 28, 2025 Telman Deborah H EVP, Corporate Affairs & GC Sell 20.0 -3,823 -8.21% ✗ $444.2K
Jul 15, 2025 Jul 16, 2025 Mercier Johanna Chief Commercial Officer Sell 38.8 -3,000 -2.50% ✓ $333.1K
Jul 15, 2025 Jul 16, 2025 Dickinson Andrew D CFO Sell 42.5 -2,500 -1.51% ✓ $277.6K
Jul 14, 2025 Jul 15, 2025 Bluestone Jeffrey Director Sell 7.5 -5,000 -35.92% ✓ $548.7K
Jun 30, 2025 Jul 1, 2025 O'Day Daniel Patrick CEO Sell 40.0 -10,000 -1.60% ✓ $1.1M
Jun 16, 2025 Jun 17, 2025 Dickinson Andrew D CFO Sell 42.5 -2,500 -1.49% ✓ $275.4K
Jun 16, 2025 Jun 17, 2025 Mercier Johanna Chief Commercial Officer Sell 38.8 -3,000 -2.44% ✓ $330.5K
Jun 10, 2025 Jun 11, 2025 Wilfong Diane E. Interim Corp Controller & CAO Sell 36.3 -340 -0.74% ✗ $37.4K
Jun 10, 2025 Jun 11, 2025 Telman Deborah H EVP, Corporate Affairs & GC Sell 26.3 -430 -1.12% ✗ $47.3K
Jun 10, 2025 Jun 11, 2025 Mercier Johanna Chief Commercial Officer Sell 22.5 -1,827 -1.46% ✗ $201.1K
Jun 10, 2025 Jun 11, 2025 O'Day Daniel Patrick CEO Sell 30.0 -4,968 -0.79% ✗ $546.9K
Jun 10, 2025 Jun 11, 2025 Dickinson Andrew D CFO Sell 22.5 -1,758 -1.04% ✗ $193.5K
Jun 5, 2025 Jun 6, 2025 GILEAD SCIENCES, INC. 10% Owner Neutral 52.5 - 0.00% ✗ -
May 30, 2025 Jun 2, 2025 O'Day Daniel Patrick CEO Sell 40.0 -10,000 -1.59% ✓ $1.1M
May 22, 2025 May 23, 2025 Mercier Johanna Chief Commercial Officer Sell 27.5 -28,000 -7.04% ✓ $3M
May 15, 2025 May 16, 2025 Dickinson Andrew D CFO Sell 45.0 -2,500 -1.49% ✓ $249.6K
May 7, 2025 May 8, 2025 Horning Sandra Director Neutral 90.0 +1,516 41.75% ✗ -
May 7, 2025 May 8, 2025 MANWANI HARISH Director Sell 86.3 +1,220 9.48% ✗ $29.3K
May 7, 2025 May 8, 2025 Kramer Kelly A. Director Neutral 52.5 - 0.00% ✗ -
May 7, 2025 May 8, 2025 Bluestone Jeffrey Director Neutral 52.5 - 0.00% ✗ -
May 7, 2025 May 8, 2025 WELTERS ANTHONY Director Neutral 90.0 +1,516 14.82% ✗ -
May 7, 2025 May 8, 2025 Rodriguez Javier Director Neutral 90.0 +1,516 14.17% ✗ -
May 7, 2025 May 8, 2025 LOVE TED W Director Neutral 90.0 +1,516 53.72% ✗ -
May 7, 2025 May 8, 2025 BARTON JACQUELINE K Director Neutral 85.0 +1,516 6.18% ✗ -
Apr 25, 2025 Apr 28, 2025 Telman Deborah H EVP, Corporate Affairs & GC Sell 43.8 -158 -0.43% ✗ $16.3K
Apr 15, 2025 Apr 16, 2025 Dickinson Andrew D CFO Sell 42.5 -2,500 -1.46% ✓ $266K
Mar 20, 2025 Wilfong Diane E. Interim Corp Controller & CAO Neutral 52.5 - 0.00% ✗ -
Mar 17, 2025 Mar 18, 2025 Dickinson Andrew D CFO Sell 42.5 -2,500 -1.44% ✓ $276.3K
Mar 10, 2025 Mar 12, 2025 Mercier Johanna Chief Commercial Officer Sell 20.0 -3,907 -3.05% ✗ $457.9K
Mar 10, 2025 Mar 12, 2025 O'Day Daniel Patrick CEO Sell 17.5 -11,632 -1.81% ✗ $1.4M
Mar 10, 2025 Mar 12, 2025 Telman Deborah H EVP, Corporate Affairs & GC Sell 22.5 -1,130 -3.00% ✗ $132.4K
Mar 10, 2025 Mar 12, 2025 Dickinson Andrew D CFO Sell 32.5 -21,784 -3.99% ✓ $2.6M
Mar 10, 2025 Mar 12, 2025 Patterson Sandra SVP, Controllership Sell 22.5 -624 -1.56% ✗ $73.1K
Mar 10, 2025 Mar 12, 2025 Berger Dietmar Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 18, 2025 Feb 20, 2025 GILEAD SCIENCES, INC. 10% Owner Buy 95.0 +1,363,636 4.54% ✗ $15M
Feb 18, 2025 Feb 19, 2025 Dickinson Andrew D CFO Sell 42.5 -2,500 -1.46% ✓ $260.2K
Feb 12, 2025 Feb 13, 2025 Dickinson Andrew D CFO Sell 2.5 -137,676 -44.57% ✓ $14.1M
Feb 4, 2025 Feb 6, 2025 Patterson Sandra SVP, Controllership Neutral 77.5 +709 1.91% ✗ -
Feb 4, 2025 Feb 6, 2025 Telman Deborah H EVP, Corporate Affairs & GC Neutral 90.0 +12,371 57.17% ✗ -
Feb 4, 2025 Feb 6, 2025 O'Day Daniel Patrick CEO Sell 100.0 +116,348 23.20% ✗ $10.6M
Feb 4, 2025 Feb 6, 2025 Mercier Johanna Chief Commercial Officer Sell 100.0 +44,839 59.67% ✗ $4.5M
Feb 4, 2025 Feb 6, 2025 Dickinson Andrew D CFO Sell 100.0 +41,350 31.84% ✗ $4.2M
Jan 31, 2025 Feb 3, 2025 Dickinson Andrew D CFO Sell 2.5 -142,180 -52.26% ✓ $13.8M
Jan 25, 2025 Jan 27, 2025 Telman Deborah H EVP, Corporate Affairs & GC Sell 36.3 -187 -0.86% ✗ $17.4K
Jan 15, 2025 Jan 16, 2025 Dickinson Andrew D CFO Sell 45.0 -2,500 -1.89% ✓ $228.4K
Jan 2, 2025 Jan 3, 2025 Berger Dietmar Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 3, 2025 Berger Dietmar Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 19, 2024 Dec 23, 2024 GILEAD SCIENCES, INC. 10% Owner Buy 100.0 +940,499 74.12% ✗ $20.1M
Dec 18, 2024 Dec 19, 2024 GILEAD SCIENCES, INC. 10% Owner Buy 100.0 +1,759,978 23.96% ✗ $1.8M
Dec 16, 2024 Dec 17, 2024 Dickinson Andrew D CFO Sell 30.0 -8,500 -6.03% ✓ $781.7K
Dec 13, 2023 Dec 16, 2024 Patterson Sandra SVP, Controllership Sell 46.3 -455 -1.21% ✗ $39.2K
Dec 10, 2024 Dec 11, 2024 Telman Deborah H EVP, Corporate Affairs & GC Sell 26.3 -306 -1.42% ✗ $28.3K